- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02812602
Topical Anesthesia for Removal of Stitches After Total Knee Arthroplasty
June 21, 2016 updated by: National Taiwan University Hospital
Topical Anesthesia With Lidocaine Patch for Removal of Metal Staples After Total Knee Arthroplasty: A Prospective Randomized Trial
Lidocaine patch is a safe and effective topical anesthetic agent for removal of metal staples after total knee replacement
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
This is a double-blind randomised control trial. After informed consent, the patients who undergoes primary total knee replacement will be assigned to either control group or experimental group randomly. The effectiveness and complication will be analysed.
If the patients are not medically fit for the study (including contraindications for lidocaine), they will be excluded.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Test2
-
Taipei, Test2, Taiwan, test3
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Ching-Chuan Jiang
- Phone Number: 65273 886-2-23123456
- Email: ccj@ntu.edu.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 100 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria:
- Males and females, aged 50-100 years
- The patients who undergo primary total knee replacement (performed by the same surgeon, Dr.Jiang)
- Clear consciousness
- No contraindication for staple removal on the post-operative day 7
Exclusion criteria:
- Allergy to lidocaine
- Patient with second or third degree atrio-ventricular block
- Patients with severe Sinoatrial node block
- Patients taking class I antiarrhythmia drugs
- Pregnant patients
- Patients undergoing revision total knee replacement
- Contraindication for removal of staples on post-operative day 7
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Lidocaine patch
The patients was randomly assigned to experimental group or placebo group.
In this arm, lidocaine patches will be applied to the skin surrounding the surgical wound by one nurse practitioner.
After more than 20 minutes the patch will be removed.
Another nurse practitioner (double blinded) will remove the metal staples and record pain scale.
|
Lidocain patch will be applied around the surgical wound about 20 minutes before removal of staples.
|
|
PLACEBO_COMPARATOR: Placebo
The patients was randomly assigned to experimental group or placebo group.
In this arm, a placebo patch will be applied to the skin surrounding the surgical wound by one nurse practitioner.
After more than 20 minutes the patch will be removed.
Another nurse practitioner (double blinded) will remove the metal staples and record pain scale.
|
Placebo patch will be applied around the surgical wound about 20 minutes before removal of staples.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual analog scale for pain
Time Frame: 30min
|
The person who removes the staples evaluated the pain intensity.
The pain intensity is evaluated with visual analog scale for pain
|
30min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complication rate of lidocaine patch
Time Frame: Two weeks
|
The incidence of related complications after application of lidocaine patch
|
Two weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ching-Chuan Jiang, Department of Orthopedic Surgery, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (ANTICIPATED)
June 1, 2016
Study Completion (ANTICIPATED)
June 1, 2016
Study Registration Dates
First Submitted
April 17, 2016
First Submitted That Met QC Criteria
June 21, 2016
First Posted (ESTIMATE)
June 24, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
June 24, 2016
Last Update Submitted That Met QC Criteria
June 21, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- 201505116MINA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metal Staple Removal After Total Knee Replacement
-
Mayo ClinicActive, not recruitingArthroplasty, Replacement, Knee | Total Knee Replacement | Blood Metal Ion ConcentrationUnited States
-
Odense University HospitalCompletedTourniquet and Outcome After Total Knee Replacement
-
Janssen Research & Development, LLCCompletedVTE Prophylaxis With Anticoagulation After Total Knee Replacement SurgeryBelgium, Italy, Malaysia, Latvia, Spain, Turkey, Bulgaria, United States, Lithuania, Russian Federation, Ukraine, Japan, Argentina, Brazil, Canada, Poland
-
Central DuPage HospitalTerminatedTotal Knee Replacement | Replacement, Total Knee | Arthroplasty, Knee ReplacementUnited States
-
Concentra AI, incRecruitingTotal Hip Replacement | Total Knee ReplacementUnited States
-
Ottawa Hospital Research InstituteThe Ottawa Hospital Academic Medical AssociationCompletedTotal Hip Replacement | Total Knee ReplacementCanada
-
National University Hospital, SingaporeActive, not recruitingKnee Replacement, Total | Knee Replacement SurgerySingapore
-
Istanbul UniversityCompleted
-
Singapore General HospitalCompletedTotal Knee Arthroplasty | Total Knee ReplacementSingapore
-
Istanbul UniversityCompletedTotal Knee Arthroplasty | Total Knee ReplacementTurkey
Clinical Trials on Lidocaine patch
-
Fayoum UniversityNot yet recruitingImpacted Third Molar Tooth
-
Aswan University HospitalUnknownCesarean Section ComplicationsEgypt
-
CRI LifetreeNuvo Research Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed
-
Corporacion Parc TauliCompletedDiabetic Neuropathy | Diabetic Nerve Problems | Diabetic Complications NeurologicalPakistan
-
Scilex Pharmaceuticals, Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed
-
Oregon Health and Science UniversityCompleted
-
Scilex Pharmaceuticals, Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed